Cefpodoxime Proxetil + Clavulanate Potassium Dry Syrup Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP manufactures Cefpodoxime Proxetil + Clavulanate Potassium Dry Syrup for pediatric bacterial infections requiring stronger antibacterial protection against resistant organisms. The formulation is widely administered in recurrent tonsillitis, sinusitis, otitis media, throat infections, and pediatric respiratory bacterial conditions.

Cefpodoxime Proxetil interferes with bacterial cell wall synthesis, while Clavulanate Potassium blocks beta-lactamase enzymes responsible for bacterial resistance. The combination is frequently utilized in pediatric infection therapies where conventional antibiotics may demonstrate reduced effectiveness against resistant bacterial strains.

Genliva Wellness LLP is engaged in pediatric dry syrup contract manufacturing in Gujarat supplying oral cephalosporin formulations to pharmaceutical distributors, pediatric healthcare suppliers, and international export markets.

Cefpodoxime Proxetil + Clavulanate Potassium Dry Syrup is developed for resistant pediatric bacterial infections.

Third-generation cephalosporin and clavulanate combination
Frequently administered in pediatric ENT infections
Enhanced antibacterial action against resistant organisms
Smooth reconstitution with uniform suspension consistency
Manufactured under stringent pharmaceutical quality standards
Intended for pediatric respiratory infection therapies

This formulation is prescribed in pediatric resistant bacterial infection management.

Treatment of tonsillitis and throat infections
Management of sinusitis and otitis media
Administered in pediatric respiratory bacterial conditions
Utilized in recurrent ENT infection therapies
Targets beta-lactamase producing bacterial strains
Frequently selected in pediatric outpatient care

Cefpodoxime Proxetil + Clavulanate Potassium Dry Syrup delivers enhanced antibacterial protection in pediatric infections.

Broad antibacterial activity against resistant bacteria
Valuable in recurrent ENT infection treatment
Convenient oral dry syrup administration for children
Improves antibacterial effectiveness in difficult infections
Frequently preferred in pediatric respiratory care
Maintains extended cephalosporin antibacterial coverage